Document Detail


A practical approach to the prevention of miscarriage: part 2--active immunotherapy.
MedLine Citation:
PMID:  20420268     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To present data suggesting that active immunization with lymphocyte immunotherapy is a treatment that has benefit in preventing miscarriage. METHODS: Lymphocyte immunotherapy is given to women with a history of recurrent miscarriage or failure to achieve a successful pregnancy, despite several previous embryo transfers. Active immunization was combined with progesterone therapy. The lymphocytes were not refrigerated, but used fresh. RESULTS: Compared to controls, i.e., progesterone therapy alone, the injection of paternal lymphocytes intradermally improved miscarriage rates and improved live delivered pregnancy rates per embryo transfer. CONCLUSIONS: The addition of progesterone treatment may act synergistically with lymphocyte immunotherapy, especially in primary aborters and tertiary aborters. However, it is important to use fresh--not refrigerated--stored lymphoctes.
Authors:
J H Check
Related Documents :
22796618 - Spontaneous remision of aplastic anemia occurring during a pregnancy.
10647748 - Hard science versus phenomenology in reproductive immunology.
14969768 - Th2/th3 cytokine genotypes are associated with pregnancy loss.
2432918 - Immunosuppressive properties of pregnancy serum on the mixed lymphocyte reaction.
16863558 - Does pregnancy change the disease course? a study in a european cohort of patients with...
18408 - Follicular development during late human pregnancy.
Publication Detail:
Type:  Editorial    
Journal Detail:
Title:  Clinical and experimental obstetrics & gynecology     Volume:  37     ISSN:  0390-6663     ISO Abbreviation:  Clin Exp Obstet Gynecol     Publication Date:  2010  
Date Detail:
Created Date:  2010-04-27     Completed Date:  2010-06-10     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802110     Medline TA:  Clin Exp Obstet Gynecol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  5-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Habitual / prevention & control*
Combined Modality Therapy
Embryo Transfer
Enzyme-Linked Immunosorbent Assay
Female
Humans
Immunotherapy, Active*
Injections, Intradermal
Live Birth
Lymphocyte Transfusion
Male
Pregnancy
Pregnancy Proteins / blood
Pregnancy Rate
Progesterone / therapeutic use
Progestins / therapeutic use
Specimen Handling
Suppressor Factors, Immunologic / blood
Chemical
Reg. No./Substance:
0/PIBF1 protein, human; 0/Pregnancy Proteins; 0/Progestins; 0/Suppressor Factors, Immunologic; 57-83-0/Progesterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Long-term survival after colonic stenting and restenting for malignant colonic obstruction.
Next Document:  Misoprostol for second trimester abortion in women with prior uterine incisions.